Tumor Biology

, Volume 36, Issue 7, pp 5299–5304 | Cite as

Association between polymorphisms in cdc27 and breast cancer in a Chinese population

  • Hui Guo
  • Wei Chen
  • Jie Ming
  • Rong Zhong
  • Pengfei Yi
  • Beibei Zhu
  • Xiaoping Miao
  • Tao Huang
Research Article


Cdc27, as a core component of anaphase-promoting complex (APC), is a cell cycle regulator, which participates in control of mitotic checkpoint and surveys the mitotic spindle to maintain chromosomal integrity. It was hypothesized that polymorphisms in cdc27 gene might contribute to the susceptibility of breast cancer (BC) through influencing the mitotic progression of cells. Therefore, a hospital-based case-control study with 463 BC patients and 536 controls was implemented to investigate the association of six single-nucleotide polymorphisms (SNPs) in cdc27 and BC risk in a Chinese Han population. Among the six SNPs, two SNPs of rs11570443 and rs12601027 were positively correlated with BC risk. Individuals carrying rs11570443-CT or CC genotypes showed a higher BC risk with the OR of 1.75 (95 % confidence interval (CI) = 1.13–1.69), compared with those carrying rs11570443-TT genotype. For rs12601027, an increased BC risk was significantly associated with homozygote TT genotype (odds ratio (OR) = 1.49, 95 % CI = 1.12–1.98) compared with homozygote CC and heterozygote CT genotypes. In addition, a significant interaction effect of these two SNPs was found. The rs12601027-TT in combination with rs11570443-CT/CC genotypes showed a strongly elevated risk of BC compared with rs12601027-CC/CT and rs11570443-TT genotype (OR = 1.95, 95 % CI = 1.06–3.59). These findings suggested that polymorphisms in cdc27 may contribute to the susceptibility of BC though functional studies are needed to further elucidate the underling mechanisms of the associations.


Breast cancer cdc27 Case-control study 



We are grateful to all the participants in this study, as well as all the persons who helped us to successfully complete the research.

Conflicts of interest


Supplementary material

13277_2015_3190_MOESM1_ESM.docx (19 kb)
ESM 1 (DOCX 18 kb)
13277_2015_3190_MOESM2_ESM.doc (57 kb)
ESM 2 (DOC 57 kb)


  1. 1.
    Ferlay J SI EM, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray, F. Cancer incidence and mortality worldwide: IARC CancerBase No. 11. GLOBOCAN 2012Google Scholar
  2. 2.
    Fan L, Strasser-Weippl K, Li JJ, St Louis J, Finkelstein DM, Yu KD, et al. Breast cancer in China. Lancet Oncol. 2014;15(7):e279–89. doi: 10.1016/s1470-2045(13)70567-9.CrossRefPubMedGoogle Scholar
  3. 3.
    Fan L, Zheng Y, Yu KD, Liu GY, Wu J, Lu JS, et al. Breast cancer in a transitional society over 18 years: trends and present status in Shanghai. China Breast Cancer Res Treat. 2009;117(2):409–16. doi: 10.1007/s10549-008-0303-z.CrossRefPubMedGoogle Scholar
  4. 4.
    Chen W, Song H, Zhong R, Zhu B, Guo H, Lou J, et al. Risk of GWAS-identified genetic variants for breast cancer in a Chinese population: a multiple interaction analysis. Breast Cancer Res Treat. 2013;142(3):637–44. doi: 10.1007/s10549-013-2775-8.CrossRefPubMedGoogle Scholar
  5. 5.
    Chen W, Wang W, Zhu B, Guo H, Sun Y, Ming J, et al. A functional variant rs1820453 in YAP1 and breast cancer risk in Chinese population. PLoS One. 2013;8(11):e79056. doi: 10.1371/journal.pone.0079056.CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Guo H, Ming J, Liu C, Li Z, Zhang N, Cheng H, et al. A common polymorphism near the ESR1 gene is associated with risk of breast cancer: evidence from a case-control study and a meta-analysis. PLoS One. 2012;7(12):e52445. doi: 10.1371/journal.pone.0052445.CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Miki Y, Swensen J, Shattuck-Eidens D, Futreal PA, Harshman K, Tavtigian S, et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science. 1994;266(5182):66–71.CrossRefPubMedGoogle Scholar
  8. 8.
    Wooster R, Bignell G, Lancaster J, Swift S, Seal S, Mangion J, et al. Identification of the breast cancer susceptibility gene BRCA2. Nature. 1995;378(6559):789–92. doi: 10.1038/378789a0.CrossRefPubMedGoogle Scholar
  9. 9.
    Ripperger T, Gadzicki D, Meindl A, Schlegelberger B. Breast cancer susceptibility: current knowledge and implications for genetic counselling. Eur J Hum Genet. 2009;17(6):722–31. doi: 10.1038/ejhg.2008.212.CrossRefPubMedGoogle Scholar
  10. 10.
    Michailidou K, Hall P, Gonzalez-Neira A, Ghoussaini M, Dennis J, Milne RL et al. Large-scale genotyping identifies 41 new loci associated with breast cancer risk. Nat Genet. 2013;45(4):353-61, 61e1-2. doi: 10.1038/ng.2563
  11. 11.
    Liu L, Yuan P, Wu C, Zhang X, Guo H, Zhong R, et al. A functional -77 T > C polymorphism in XRCC1 is associated with risk of breast cancer. Breast Cancer Res Treat. 2011;125(2):479–87. doi: 10.1007/s10549-010-0959-z.CrossRefPubMedGoogle Scholar
  12. 12.
    Zhang B, Beeghly-Fadiel A, Long J, Zheng W. Genetic variants associated with breast-cancer risk: comprehensive research synopsis, meta-analysis, and epidemiological evidence. Lancet Oncol. 2011;12(5):477–88. doi: 10.1016/s1470-2045(11)70076-6.CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Ho PP, Couch FJ, Brody LC, Abel KJ, Boehnke M, Shearon TH, et al. Localization of the human homolog of the yeast cell division control 27 gene (CDC27) proximal to ITGB3 on human chromosome 17q21.3. Somat Cell Mol Genet. 1995;21(5):351–5.CrossRefPubMedGoogle Scholar
  14. 14.
    Thornton BR, Ng TM, Matyskiela ME, Carroll CW, Morgan DO, Toczyski DP. An architectural map of the anaphase-promoting complex. Genes Dev. 2006;20(4):449–60. doi: 10.1101/gad.1396906.CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Park KH, Choi SE, Eom M, Kang Y. Downregulation of the anaphase-promoting complex (APC)7 in invasive ductal carcinomas of the breast and its clinicopathologic relationships. Breast Cancer Res. 2005;7(2):R238–47. doi: 10.1186/bcr978.CrossRefPubMedPubMedCentralGoogle Scholar
  16. 16.
    Pawar SA, Sarkar TR, Balamurugan K, Sharan S, Wang J, Zhang Y, et al. C/EBP{delta} targets cyclin D1 for proteasome-mediated degradation via induction of CDC27/APC3 expression. Proc Natl Acad Sci U S A. 2010;107(20):9210–5. doi: 10.1073/pnas.0913813107.CrossRefPubMedPubMedCentralGoogle Scholar
  17. 17.
    Stephens M, Smith NJ, Donnelly P. A new statistical method for haplotype reconstruction from population data. Am J Hum Genet. 2001;68(4):978–89. doi: 10.1086/319501.CrossRefPubMedPubMedCentralGoogle Scholar
  18. 18.
    Talvinen K, Karra H, Pitkanen R, Ahonen I, Nykanen M, Lintunen M, et al. Low cdc27 and high securin expression predict short survival for breast cancer patients. APMIS. 2013;121(10):945–53. doi: 10.1111/apm.12110.CrossRefPubMedGoogle Scholar
  19. 19.
    Izawa D, Pines J. How APC/C-Cdc20 changes its substrate specificity in mitosis. Nat Cell Biol. 2011;13(3):223–33. doi: 10.1038/ncb2165.CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    Roy D, Arason GA, Chowdhury B, Mitra A, Calaf GM. Profiling of cell cycle genes of breast cells exposed to etodolac. Oncol Rep. 2010;23(5):1383–91.CrossRefPubMedGoogle Scholar
  21. 21.
    Silva JM, Marran K, Parker JS, Silva J, Golding M, Schlabach MR, et al. Profiling essential genes in human mammary cells by multiplex RNAi screening. Science. 2008;319(5863):617–20. doi: 10.1126/science.1149185.CrossRefPubMedPubMedCentralGoogle Scholar
  22. 22.
    Stevens KN, Wang X, Fredericksen Z, Pankratz VS, Cerhan J, Vachon CM, et al. Evaluation of associations between common variation in mitotic regulatory pathways and risk of overall and high grade breast cancer. Breast Cancer Res Treat. 2011;129(2):617–22. doi: 10.1007/s10549-011-1587-y.CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© International Society of Oncology and BioMarkers (ISOBM) 2015

Authors and Affiliations

  1. 1.Department of Breast and Thyroid Surgery, Union Hospital, Tongji Medical CollegeHuazhong University of Science and TechnologyWuhanChina
  2. 2.State Key Laboratory of Environment Health (Incubation), MOE (Ministry of Education) Key Laboratory of Environment & Health, Ministry of Environmental Protection Key Laboratory of Environment and Health (Wuhan), and Department of Epidemiology and Biostatistics, School of Public Health, Tongji Medical CollegeHuazhong University of Science and TechnologyWuhanChina

Personalised recommendations